Targeting regulation of the tumour microenvironment induces apoptosis of breast cancer cells by an affinity hemoperfusion adsorbent

References

• Hoshino A, Costa-Silva B, Shen T-L, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329–335.
   PubMed Web of Science ®Google Scholar
• Xu J, Shen L, Zhou Z, et al. Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind. Placebo-Controlled, Phase 3 Study, the Lancet Oncology. 2020;21(11):1500–1512.
   PubMed Web of Science ®Google Scholar
• Valtola R, Salven P, Heikkilä P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol. 1999;154(5):1381–1390.
   PubMed Web of Science ®Google Scholar
• Weigand M, Hantel P, Kreienberg R, et al. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis. 2005;8(3):197–204.
   PubMedGoogle Scholar
• Dumont N, Arteaga CL. Transforming growth factor-beta and breast cancer: tumor promoting effects of transforming growth factor-beta. Breast Cancer Res. 2000;2(2):125–132.
   PubMed Web of Science ®Google Scholar
• Victor F, Gottlieb A. TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis. J Drugs Dermatol. 2002;1(3):264–275.
   PubMedGoogle Scholar
• Sheu B-C, Chang W-C, Cheng C-Y, et al. Cytokine regulation networks in the cancer microenvironment. Front Biosci. 2008;13(13):6255–6268.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Hillan KJ, Gerber H-P, et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004;3(5):391–400.
   PubMed Web of Science ®Google Scholar
• Willett CG, Boucher Y, Tomaso ED, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10(2):145–147.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Ueda Y, Itoh T, et al. A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats. Oncol Rep. 2006;16(6):1277–1284.
   PubMed Web of Science ®Google Scholar
• Yu YT, Zhu H, Wang S. Amphiphilic polyvinyl alcohol adsorbent for the removal of low-density lipoprotein, artificial cells. Artif Cells Nanomed Biotechnol. 2015;43(2):117–123.
   PubMed Web of Science ®Google Scholar
• Wang W, Xie H, Sun L, et al. Macroporous poly(vinyl alcohol) microspheres bearing phosphate groups as a new adsorbent for low-density lipoprotein apheresis . Biomed Mater. 2009;4(6):065007.
   PubMed Web of Science ®Google Scholar
• Ma K-W, Ma L, Cai S-X, et al. Preparation of heparin-immobilized PVA and its adsorption for low-density lipoprotein from hyperlipemia plasma. J Mater Sci Mater Med. 2008;19(10):3255–3261.
   PubMed Web of Science ®Google Scholar
• Zhao W, McCallum SA, Xiao Z, et al. Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides. Biosci Rep. 2012;32(1):71–81.
   PubMed Web of Science ®Google Scholar
• Impellitteri NA, Toepke MW, Levengood SKL, et al. Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres. Biomaterials. 2012;33(12):3475–3484.
   PubMed Web of Science ®Google Scholar
• Chen J, Han W, Su R, et al. Non-ionic macroporous polystyrene adsorbents for removal of serum toxins in liver failure by hemoperfusion. Artif Cells Nanomed Biotechnol. 2017;45(1):174–183.
   PubMed Web of Science ®Google Scholar
• Zong W, Chen J, Han W, et al. Preparation of PVA/amino multi-walled carbon nanotubes nanocomposite microspheres for endotoxin adsorption. Artif Cells Nanomed Biotechnol. 2018;46(1):185–191.
   PubMed Web of Science ®Google Scholar
• Wei H, Han L, Tang Y, et al. Highly flexible heparin-modified chitosan/graphene oxide hybrid hydrogel as a super bilirubin adsorbent with excellent hemocompatibility. J Mater Chem B. 2015;3(8):1646–1654.
   PubMed Web of Science ®Google Scholar
• Cheng G, Chai Y, Chen J, et al. Polystyrene-divinylbenzene based nano-CaCO3 composites for the efficient removal of human tumor necrosis factor-α. Chem Commun. 2017;53(55):7744–7747.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhao W, Guo H, et al. Metal-organic framework traps with record-high bilirubin removal capacity for hemoperfusion therapy. ACS Appl Mater Interfaces. 2020;12(23):25546–25556.
   PubMed Web of Science ®Google Scholar
• Song M, Winchester J, Albright RL, et al. Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004;22(5):428–434.
   PubMed Web of Science ®Google Scholar
• Johnson RW, Finger EC, Olcina MM, et al. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016;18(10):1078–1089.
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Kersten K, Doornebal CW, et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345–348.
   PubMed Web of Science ®Google Scholar
• Mombaerts P, Iacomini J, Johnson RS, et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68(5):869–877.
   PubMed Web of Science ®Google Scholar
• Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, et al. High prevalence and breast cancer predisposing role of the BLM c.1642 C > T (Q548X) mutation in Russia. Int J Cancer. 2012;130(12):2867–2873.
   PubMed Web of Science ®Google Scholar
• Labelle-Côté M, Dusseault J, Ismaïl S, et al. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo. BMC Cancer. 2011;11(1):443.
   PubMed Web of Science ®Google Scholar
• Cleveland RJ, Gammon MD, Long C-M, et al. Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival. Breast Cancer Res Treat. 2010;120(3):745–752.
   PubMed Web of Science ®Google Scholar
• Gonzalez RR, Cherfils S, Escobar M, et al. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem. 2006;281(36):26320–26328.
   PubMed Web of Science ®Google Scholar
• Uría JA, Ferrando AA, Velasco G, et al. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res. 1994;54(8):2091–2094.
   PubMed Web of Science ®Google Scholar
• Burwinkel B, Schmutzhard J, Tchatchou S, et al. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis. 2006;27(11):2201–2208.
   PubMed Web of Science ®Google Scholar
• Beck TN, Nicolas E, Kopp MC, et al. Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease. Oncoscience. 2014;1(7):486–503.
   PubMedGoogle Scholar
• Hughes S, Agbaje O, Bowen RL, et al. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res. 2007;13(22):6673–6680.
   PubMed Web of Science ®Google Scholar
• Acharyya S, Oskarsson T, Vanharanta S, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150(1):165–178.
   PubMed Web of Science ®Google Scholar
• Brennan KR, Brown AMC. Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia. 2004;9(2):119–131.
   PubMed Web of Science ®Google Scholar
• Bui TD, Rankin J, Smith K, et al. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene. 1997;14(10):1249–1253.
   PubMed Web of Science ®Google Scholar
• Hamamoto R, Silva FP, Tsuge M, et al. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci. 2006;97(2):113–118.
   PubMed Web of Science ®Google Scholar
• Xiang Y-Y, Ladeda V, Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene. 2001;20(50):7408–7412.
   PubMed Web of Science ®Google Scholar
• Colander D, Holmes J. Gender and graduate economics education in the US. Feminist Econ. 2007;13(2):93–116.
   Web of Science ®Google Scholar
• Dong C, Wu Y, Wang Y, et al. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene. 2013;32(11):1351–1362.
   PubMed Web of Science ®Google Scholar
• Ding L, Niu C, Zheng Y, et al. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth. J Cell Mol Med. 2011;15(1):72–85.
   PubMed Web of Science ®Google Scholar
• Li X, Jia Z, Shen Y, et al. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Cancer Sci. 2008;99(7):1326–1333.
   PubMed Web of Science ®Google Scholar